Imperative Care, Inc. announced the appointment of Todd Van Horn as Chief Financial Officer.
“Imperative Care is deeply committed to bringing together a strong balance of leaders with complementary expertise and a shared passion for elevating patient care,” said Fred Khosravi, CEO of Imperative Care. “We are very pleased to welcome Todd at this important moment for Imperative Care, as we strengthen our financial position and focus on scaling our hypergrowth thrombectomy technologies to address runaway clot throughout the body and bring better care to more patients globally.”
Health Technology Insights: ERPHealth partners with Penn State to help prevent substance use disorder
Mr. Van Horn brings more than two decades of leadership experience in finance, business development, strategy, operations, and organizational transformation at global medical device and life sciences companies. Most recently, he served as Chief Operating Officer and then, Chief Business Officer at Candela Medical, where he led the operational aspects of a comprehensive turnaround that improved growth, focused strategy, and increased profit margins. Prior to Candela, Mr. Van Horn served in roles of increasing responsibility at Cord Blood Registry, most recently as its General Manager, both when it was an independent company and as a subsidiary of AMAG Pharmaceuticals.
Health Technology Insights: The Future of AI & Electrophysiology Takes Center Stage at Heart Rhythm 2025 with Vektor Medical
“Imperative Care has brought forward transformative technologies to address stroke and vascular disease, creating meaningful improvements in patient outcomes,” said Mr. Van Horn. “I am very excited to be joining the Imperative Care leadership team to help position the company for the future and grow its global impact on patient care.”
Mr. Van Horn spent the first decade of his career investing in and advising life science and healthcare businesses as a private equity investor at Linden Capital Partners and prior to that as an investment banker. He holds an MBA from Northwestern University’s Kellogg School of Management and a Bachelor of Science in Molecular, Cell, and Developmental Biology from UCLA.
Health Technology Insights: Inocras, Center for Data-Driven Discovery Collaborate on Sinonasal Cancer
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
